Streetbeat News

Revenues

AEYE

AMST

BOF

AudioEye, Amesite, and BranchOut Food experienced significant stock movements due to recent developments. AudioEye reported better-than-expected Q1 financial results, leading to a 21% increase in its shares. Amesite announced the Beta release of its NurseMagic app, causing its shares to surge by 75%. BranchOut Food expanded its third contract with the nation's largest retailer, reaching $8M in annualized revenue, marking a significant milestone for the company.

Portfolio Pulse from ryanfaloona@benzinga.com

April 24, 2024 | 12:30 pm

SFNC

Simmons First Ntl (NASDAQ:SFNC) reported Q1 2024 earnings of $0.32 per share, meeting analyst estimates, but missed revenue forecasts with $195.090M against an expected $202.348M. This represents a 12.78% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 12:12 pm

RBBN

Ribbon Communications projects its Q2 2024 revenue to be between $200M-$210M, with non-GAAP gross margin expected to be 53.5%-54.5% and adjusted EBITDA between $20M-$25M. This forecast is slightly below the estimated $208.21M.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 12:11 pm

BOF

WMT

BranchOut Food has expanded its contract with Walmart, the nation's largest retailer, by $300,000, bringing the total annualized value to over $8M. BranchOut's dried fruit products are set to enter 1,400 stores in September 2024.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 12:08 pm

SFNC

Simmons First Ntl (NASDAQ:SFNC) reported Q1 adjusted earnings of $0.32 per share, meeting analyst estimates but marking a 13.51% decrease from last year. Quarterly sales of $195.09M missed estimates by 3.59% and fell 12.78% year-over-year.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 12:03 pm

PII

Analysts have diverse opinions on Polaris (NYSE:PII), with recent evaluations showing a mix of bullish to bearish sentiments. The average 12-month price target for PII is $100.57, a slight decrease from previous targets. Polaris, known for its off-road and on-road vehicles, faces a -4.78% revenue decline but maintains strong profitability indicators such as net margin and ROE. However, its high debt-to-equity ratio poses financial management challenges.

Portfolio Pulse from Benzinga Insights

April 24, 2024 | 12:01 pm

DGX

Analysts have mixed views on Quest Diagnostics (NYSE:DGX), with ratings ranging from bullish to bearish over the last quarter. The average 12-month price target for DGX is $147.0, slightly up from the previous $146.67. Recent analyst actions include ratings and price target adjustments by Mizuho, Truist Securities, Leerink Partners, and Jefferies, reflecting varied expectations for the company's performance. Quest Diagnostics, a leading diagnostic services provider, shows a negative revenue trend with a -1.93% growth over 3 months, yet maintains strong profitability indicators such as an 8.39% net margin and above-average ROE and ROA.

Portfolio Pulse from Benzinga Insights

April 24, 2024 | 12:01 pm

ELV

Analyst ratings for Elevance Health (NYSE:ELV) show a mix of bullish to bearish sentiments among 13 analysts over the last quarter, with a positive shift in the 12-month price targets to an average of $586.0. The company, a leading health insurer in the U.S., has seen a revenue growth rate of 0.96% as of March 31, 2024, and outperforms in net margin and ROE, despite a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

April 24, 2024 | 12:01 pm

ABNB

Analyst ratings for Airbnb (NASDAQ:ABNB) over the last three months show diverse opinions, with a recent shift towards more positive evaluations. The average 12-month price target has increased to $153.33 from $136.62, indicating a bullish outlook from some analysts. Airbnb's financial performance shows solid revenue growth but challenges in profitability and asset utilization. The company's market capitalization and growth rate are above industry averages, yet it struggles with net margin, ROE, and ROA.

Portfolio Pulse from Benzinga Insights

April 24, 2024 | 12:00 pm

ENVA

Enova International (NYSE:ENVA) received mixed analyst ratings with an updated average 12-month price target of $71.25, reflecting an 8.78% increase from the previous target. Analysts from JMP Securities, Jefferies, and BMO Capital have raised their price targets, indicating a positive outlook on the company's performance. Enova, providing online financial services mainly in the US and UK, has shown remarkable revenue growth of 20.04% and strong financial metrics including a net margin of 5.96%, ROE of 2.78%, and ROA of 0.8%.

Portfolio Pulse from Benzinga Insights

April 24, 2024 | 12:00 pm